000 01523 a2200421 4500
005 20250516003645.0
264 0 _c20110315
008 201103s 0 0 eng d
022 _a1549-4918
024 7 _a10.1002/stem.533
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMohr, Andrea
245 0 0 _aTargeting of XIAP combined with systemic mesenchymal stem cell-mediated delivery of sTRAIL ligand inhibits metastatic growth of pancreatic carcinoma cells.
_h[electronic resource]
260 _bStem cells (Dayton, Ohio)
_cNov 2010
300 _a2109-20 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aApoptosis
_xphysiology
650 0 4 _aBlotting, Western
650 0 4 _aCell Differentiation
650 0 4 _aCell Line, Tumor
650 0 4 _aEnzyme-Linked Immunosorbent Assay
650 0 4 _aHumans
650 0 4 _aMesenchymal Stem Cells
_xmetabolism
650 0 4 _aMice
650 0 4 _aMice, Nude
650 0 4 _aPancreatic Neoplasms
_xtherapy
650 0 4 _aTNF-Related Apoptosis-Inducing Ligand
_xgenetics
650 0 4 _aX-Linked Inhibitor of Apoptosis Protein
_xgenetics
700 1 _aAlbarenque, Stella Maris
700 1 _aDeedigan, Laura
700 1 _aYu, Rui
700 1 _aReidy, Mairead
700 1 _aFulda, Simone
700 1 _aZwacka, Ralf Michael
773 0 _tStem cells (Dayton, Ohio)
_gvol. 28
_gno. 11
_gp. 2109-20
856 4 0 _uhttps://doi.org/10.1002/stem.533
_zAvailable from publisher's website
999 _c20210808
_d20210808